Search Thermo Fisher Scientific
Untargeted metabolomics usually involves comparing the metabolome of control and test groups to identify differences between their metabolite profiles. These metabolomic differences may be relevant to specific biological conditions.
There are typically three steps in an untargeted metabolomics workflow:
In an untargeted metabolomics workflow, analytical or technical reproducibility and stringent data analysis are the keys to a successful experiment. High analytical reproducibility means that the data are a direct expression of biological variance; it also allows a smaller number of samples to be tested because technical replicates are minimized.
The four steps in the profiling workflow include the following:
After profiling, the compounds or metabolites are typically identified or annotated.
High resolution accurate mass (HRAM) features derived from profiling experiments are searched against MS databases or MS/MS spectral libraries such as mzCloud, METLIN and HMDB.
Accurate mass electron ionization (EI) fragment patterns are matched against the widely available NIST and Wiley libraries for compound identification.
There are several ways to interpret and display the data once all metabolites have been identified. For example, interactive graphic displays map identified metabolites and position them on pathways that help to deduce their function.
Because knowledge about biological processes has been continuously increasing, groups of metabolites that are related to the same biological process can be placed onto unique metabolic pathways. There are also many biological databases available, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) and MetaCyc.
In an untargeted metabolomics workflow, analytical or technical reproducibility and stringent data analysis are the keys to a successful experiment. High analytical reproducibility means that the data are a direct expression of biological variance; it also allows a smaller number of samples to be tested because technical replicates are minimized.
The four steps in the profiling workflow include the following:
After profiling, the compounds or metabolites are typically identified or annotated.
High resolution accurate mass (HRAM) features derived from profiling experiments are searched against MS databases or MS/MS spectral libraries such as mzCloud, METLIN and HMDB.
Accurate mass electron ionization (EI) fragment patterns are matched against the widely available NIST and Wiley libraries for compound identification.
There are several ways to interpret and display the data once all metabolites have been identified. For example, interactive graphic displays map identified metabolites and position them on pathways that help to deduce their function.
Because knowledge about biological processes has been continuously increasing, groups of metabolites that are related to the same biological process can be placed onto unique metabolic pathways. There are also many biological databases available, such as the Kyoto Encyclopedia of Genes and Genomes (KEGG) and MetaCyc.
Learn how Dr. James McCullagh and his group at the University of Oxford are using IC-MS to characterize and quantify metabolites in order to profile the changes in central metabolism that are associated with brain tumors.